Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Dec;32(12):4037-40.
doi: 10.1007/s00296-010-1613-0. Epub 2010 Oct 30.

Kawasaki syndrome and concurrent Coxsackie virus B3 infection

Donato Rigante  1 , Luca Cantarini, Marco Piastra, Donatella Francesca Angelone, Piero Valentini, Manuela Pardeo, Danilo Buonsenso, Angelica Bibiana Delogu, Daniele Serranti, Alessia De Nisco, Adele Compagnone, Gabriella De Rosa
Affiliations
Case Reports

Kawasaki syndrome and concurrent Coxsackie virus B3 infection

Donato Rigante et al. Rheumatol Int. 2012 Dec.

Abstract

We describe two previously healthy children who were hospitalized in the same period in different departments of our University with clinical signs of Kawasaki syndrome, which were treated with intravenous immunoglobulins and acetylsalicylic acid: in both cases, Coxsackie virus infection was concurrently demonstrated by enzyme-linked immunosorbent assay, and complement fixation test identified antibodies to serotype B3. In the acute phase, both patients presented hyperechogenic coronary arteries, but no cardiologic sequels in the mid term. The etiological relationship between Kawasaki syndrome and Coxsackie viruses is only hypothetical; however, the eventual identification of ad hoc environmental triggers is advisable in front of children with Kawasaki syndrome, with the aim of optimizing epidemiological surveillance and understanding the intimate biological events of this condition.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Echocardiogram in patient 2 showing a hyperechogenic aspect (arrow) of the right coronary artery (RCA)
See this image and copyright information in PMC

References

    1. Kawasaki T, Kosaki F, Osawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–276. - PubMed
    1. De Rosa G, Pardeo M, Rigante D. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci. 2007;11:301–308. - PubMed
    1. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K. Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) Pediatr Int. 2005;47:232–234. doi: 10.1111/j.1442-200x.2005.02033.x. - DOI - PubMed
    1. Falcini F. Kawasaki disease. Curr Opin Rheumatol. 2006;18:33–38. doi: 10.1097/01.bor.0000197998.50450.f6. - DOI - PubMed
    1. Rigante D, Valentini P, Rizzo D, Leo A, De Rosa G, Onesimo R, De Nisco A, Angelone DF, Compagnone A, Delogu AB. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-centre cohort of Italian patients with Kawasaki syndrome. Rheumatol Int. 2010;30:841–846. doi: 10.1007/s00296-009-1337-1. - DOI - PubMed

Publication types

MeSH terms